tradingkey.logo

ICAD Inc

ICAD
View Detailed Chart

3.870USD

0.0000.00%
Close 08/01, 16:00ETQuotes delayed by 15 min
105.19MMarket Cap
LossP/E TTM

ICAD Inc

3.870

0.0000.00%
Intraday
1m
30m
1h
D
W
M
D

Today

+3.75%

5 Days

+Infinity%

1 Month

+2.93%

6 Months

+26.47%

Year to Date

+111.48%

1 Year

+190.98%

View Detailed Chart

Agency Rating

No Data

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

1m
15m
30m
1h
D
W
M
1m
15m
30m
D
Neutral
Sell(4)
Neutral(0)
Buy(6)
Indicators
Sell(4)
Neutral(0)
Buy(0)
Indicators
Value
Direction
MACD(12,26,9)
-0.491
Sell
RSI(14)
11.166
Oversold
STOCH(KDJ)(9,3,3)
24.664
Sell
ATR(14)
0.408
High Vlolatility
CCI(14)
-466.667
Oversold
Williams %R
100.000
Oversold
TRIX(12,20)
-0.342
Sell
StochRSI(14)
0.000
Sell
Moving Average
Sell(0)
Neutral(0)
Buy(6)
Indicators
Value
Direction
MA5
3.032
Buy
MA10
3.412
Buy
MA20
3.585
Buy
MA50
3.716
Buy
MA100
3.079
Buy
MA200
2.588
Buy

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

iCAD, Inc. provides artificial intelligence-powered cancer detection. Its ProFound Breast Health Suite enables medical providers and professionals to accurately and reliably identify where cancer may be hiding. Its Cancer Detection segment solutions include advanced artificial intelligence and image analysis workflow solutions that enable healthcare professionals to better serve patients by identifying pathologies and pinpointing the prevalent cancers earlier, a range of upgradeable computer-aided detection systems and workflow solutions for digital breast tomosynthesis, full-field digital mammography, magnetic resonance imaging and computed tomography. ProFound Suite offers 360-degree solutions for cancer detection, density assessment, and personalized risk evaluation, all based on a 2D or 3D mammogram’s collection of images. ProFound Density Assessment standardizes and simplifies breast density reporting, algorithmically examining a woman’s breast anatomy from the mammogram image.
Ticker SymbolICAD
CompanyICAD Inc
CEOMs. Dana R. Brown
Websitehttps://www.icadmed.com/
KeyAI